Pieris Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of PIRS for the last quarter is 1.30 M USD, and it's 93.35% lower compared to the previous quarter. The net income of Q4 23 is -4.58 M USD.